The Joint Corp. (JYNT)
The Joint Corp. (JYNT) is a healthcare company specializing in chiropractic care. It operates a network of franchise clinics focused on providing non-invasive, drug-free treatment for musculoskeletal conditions. Founded in 2010, the company emphasizes accessible, affordable chiropractic services through a franchise business model.
Company News
The Joint Corp. announced plans to restate its 2024 and Q1 2025 financial statements due to overestimated noncash impairment charges, expecting to reduce net loss by $2.2 million and increase net income by $0.5 million.
The Joint Chiropractic has been named the top franchise in chiropractic services by Entrepreneur Magazine's Franchise 500, jumping 29 spots to rank No. 54 on the 2025 list.
Valneva's single-dose Chikungunya vaccine, IXCHIQ, has received marketing authorization from the European Commission. This approval follows the FDA's nod in November 2023 and positions Valneva to protect European populations against Chikungunya outbreaks. The global Chikungunya vaccine market is expected to grow significantly, driven by rising medical needs and increased vaccine research and development.
Shares of small-cap healthcare company The Joint Corp. have been crushed. Did this create a nice buying opportunity?